"Heart failure and kidney failure often go hand in hand," he told Newsweek, adding that the kidneys control the way the body handles salt and water. If they are not getting rid of these substances ...

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

In the assessment done by DelveInsight, the estimated total diagnosed prevalent cases of chronic kidney disease in the US ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

Cynata Therapeutics Limited ( OTCPK:CYYNF) Investor Webinar Conference Call February 5, 2025 6:30 PM ET Lauren Nowak - Media Relations Kilian Kelly - Chief Executive Officer and Managing Director ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- "Yo-yo" dieting -- repeatedly losing and gaining weight -- can significantly ...

A recent modeling study has identified risk factors predictive of good and bad outcomes in non-diabetic CKD, such as gender, ...

children. For example, CKD in babies is most likely caused by birth defects or genetic illnesses, while adult CKD is most likely caused by non-communicable diseases including diabetes and high blood ...

Share on Pinterest The FDA approved Ozempic to help lower chronic kidney disease-related risks in people with type 2 diabetes. urbazon/Getty Images The Food and Drug Administration (FDA ...

With the FDA's approval, the medicine, chemically known as semaglutide, will become the first GLP-1 treatment option for persons with type 2 diabetes and chronic kidney disease. “Such an ...